The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators, totaling $1,000,000 in additional funding. The Continuation Grants are designed to support Clinical ...

HistoSonics, the manufacturer of the Edison® Histotripsy System, today announced that Highmark Blue Cross Blue Shield has ...

The global Liver Cancer Diagnostics Market is valued at USD 11.5 Billion in 2024 and is projected to reach a value of USD ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...

The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

The National Cancer Institute and University of Oxford report that oral contraceptive use is not associated with increased ...

The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...